MX9301192A - Uso de interleuquina-10 para suprimir la enfermedad de injerto-versus-huesped. - Google Patents

Uso de interleuquina-10 para suprimir la enfermedad de injerto-versus-huesped.

Info

Publication number
MX9301192A
MX9301192A MX9301192A MX9301192A MX9301192A MX 9301192 A MX9301192 A MX 9301192A MX 9301192 A MX9301192 A MX 9301192A MX 9301192 A MX9301192 A MX 9301192A MX 9301192 A MX9301192 A MX 9301192A
Authority
MX
Mexico
Prior art keywords
interleukin
disease
guest
versus
suppress graft
Prior art date
Application number
MX9301192A
Other languages
English (en)
Spanish (es)
Inventor
Maria-Grazia Roncarolo
Rene De Waal Malefyt
Rosa Bacchetta
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of MX9301192A publication Critical patent/MX9301192A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/001—Preparations to induce tolerance to non-self, e.g. prior to transplantation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2066—IL-10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K2035/122—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells for inducing tolerance or supression of immune responses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5158—Antigen-pulsed cells, e.g. T-cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/50—Cell markers; Cell surface determinants
    • C12N2501/515—CD3, T-cell receptor complex

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Transplantation (AREA)
  • Mycology (AREA)
  • Plant Pathology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
MX9301192A 1992-03-04 1993-03-03 Uso de interleuquina-10 para suprimir la enfermedad de injerto-versus-huesped. MX9301192A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US84620892A 1992-03-04 1992-03-04

Publications (1)

Publication Number Publication Date
MX9301192A true MX9301192A (es) 1994-08-31

Family

ID=25297256

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9301192A MX9301192A (es) 1992-03-04 1993-03-03 Uso de interleuquina-10 para suprimir la enfermedad de injerto-versus-huesped.

Country Status (11)

Country Link
EP (1) EP0629130A1 (fr)
JP (1) JPH07504437A (fr)
KR (1) KR950700079A (fr)
CN (1) CN1079166A (fr)
AU (1) AU679908B2 (fr)
CA (1) CA2131524A1 (fr)
IL (1) IL104916A0 (fr)
MX (1) MX9301192A (fr)
NZ (1) NZ249754A (fr)
WO (1) WO1993017698A1 (fr)
ZA (1) ZA931489B (fr)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08510719A (ja) * 1993-02-01 1996-11-12 ユニヴェルシテ リブル ドゥ ブリュッセル アンスティテュション ダンセニュマン ユニヴェルシテル 有効量のインターロイキン−１０、その類似体および／または作動薬を含有する医薬組成物の使用
US5573764A (en) * 1994-01-21 1996-11-12 Genetics Institute, Inc. Use of interleukin-12 to prevent graft versus host disease
AP690A (en) * 1994-07-05 1998-10-16 Steeno Res Group A/S Immunomodulators based on a polypeptide other than human interleukin 10.
CA2216090A1 (fr) * 1995-03-23 1996-09-26 Governors Of Dalhousie College And University Procede permettant de prolonger la survie d'une greffe allogenique d'organe
AU712606B2 (en) * 1995-08-09 1999-11-11 Schering Corporation Combined use of interleukin-10 and cyclosporin for immunosuppression therapy
US6022536A (en) * 1995-08-09 2000-02-08 Schering Corporation Combined use of interleukin 10 and cyclosporin for immunosuppression therapy
WO1997026278A1 (fr) 1996-01-18 1997-07-24 Steeno Research Group A/S Analogues synthetiques d'il-10
US6090413A (en) * 1996-03-25 2000-07-18 Lee; Timothy D. Process of prolonging organ allograft survival
WO1998010792A1 (fr) * 1996-09-11 1998-03-19 Prendergast Patrick T Therapie a but immunitaire
WO1998020033A2 (fr) * 1996-11-06 1998-05-14 Schering Corporation RENATURATION ET PURIFICATION DE L'INTERLEUKINE-10 VIRALE (vIL-10)
US6358506B1 (en) 1997-11-05 2002-03-19 University Of Southern California Use of cytokines and mitogens to inhibit pathological immune responses
WO1999030730A1 (fr) * 1997-12-15 1999-06-24 Universite Laval Procedes et compositions permettant d'ameliorer la reussite de la transplantation cellulaire chez un receveur
US6803036B1 (en) 1998-03-03 2004-10-12 University Of Southern California Use of cytokines, cells and mitogens to inhibit graft versus host disease
US6447765B1 (en) 1998-03-03 2002-09-10 University Of Southern California Use of cytokines and mitogens to inhibit graft versus host disease
US6759035B2 (en) 2000-04-11 2004-07-06 University Of Southen California Method to prevent graft rejection using TGF-beta to induce T suppressor cells
CN105106214A (zh) * 2015-08-05 2015-12-02 范国煌 抑制移植物抗宿主病的新型Lck的小分子抑制剂
SG10201606949QA (en) 2016-08-19 2018-03-28 Singapore Health Serv Pte Ltd Immunosuppressive composition for use in treating immunological disorders

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL94878A (en) * 1989-06-28 2003-01-12 Schering Corp Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same

Also Published As

Publication number Publication date
IL104916A0 (en) 1993-07-08
KR950700079A (ko) 1995-01-16
NZ249754A (en) 1997-06-24
EP0629130A1 (fr) 1994-12-21
ZA931489B (en) 1993-10-28
CN1079166A (zh) 1993-12-08
WO1993017698A1 (fr) 1993-09-16
AU3732893A (en) 1993-10-05
AU679908B2 (en) 1997-07-17
CA2131524A1 (fr) 1993-09-16
JPH07504437A (ja) 1995-05-18

Similar Documents

Publication Publication Date Title
MX9301192A (es) Uso de interleuquina-10 para suprimir la enfermedad de injerto-versus-huesped.
NO944997D0 (no) Trombin-blodfraksjon for anvendelse ved en medisinsk fremgangsmåte
EA199900168A1 (ru) Применение glp-1 или его аналогов в лечении инфаркта миокарда
IT9067127A0 (it) Anello di sutura per protesi valvolari cardiache
ES2029905T3 (es) Implantacion para fijar protesis dental.
ATE208620T1 (de) Kombinationspräparat zur anwendung bei immunologischen erkrankungen
ES1017741Y (es) Acoplamiento para protesis de extremidades.
SE8404707L (sv) Komposition innehallande pyridinlosligt extrakt och raffinerat detoxifierat endotoxin samt anvendning derav
FI933193A0 (fi) Behandling av neoplastisk sjukdom med interleukin-10
AR044235A2 (es) Uso de una composicion que comprende merozoitos de eimeria vivos
SE8602241L (sv) Hudregenererande och hydratiserande kosmetiska kompositioner och forfarande for framstellning av den aktiva ingrediensen
MX7636E (es) Un metodo para la preparacion de una vacuna para la proteccion de aves de corral contra la bronquitis infecciosa
RU95103436A (ru) Способ замедления прогрессирования атеросклероза коронарных артерий с помощью правастатина
ES2106031T3 (es) Una composicion comprendiendo un factor de crecimiento, su metodo de obtencion y uso.
FI954367A0 (fi) Substituoitujen alkyylinitraattien käyttö patologisesti kohonneen intraokulaarisen paineen hoitamiseksi
ES2175051T3 (es) Uso de un pliholosido en una composicion limpiadora o desmaquillante y composicion que lo incluye.
MX9302878A (es) Procedimiento para la preparacion de un diaminodiol substituido.
DE3772051D1 (de) Prothese zur expansion des hautgewebes.
ES2166834T3 (es) Uso de agentes antiviricos de aminopurina para el tratamiento y profilaxis de infecciones latentes de herpesvirus.
MX9301605A (es) Dispositivo de insercion endoscopico para insertar un anillo para anastomosis.
MX9206135A (es) Metodos
UA19335A (uk) Спосіб приготуваhhя засобу для лікуваhhя хвороб типу псоріазу
FI870890A (fi) Antiglaucomafoereningar.
ES2039516T3 (es) Empleo de los enantiomeros de la propafenona para la obtencion de medicamentos.
MY100443A (en) Topical preparation for treating herpes simplex virus infection